Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Kodiak Sciences (KOD) Other financing activities (2018 - 2026)

Kodiak Sciences filings provide 3 years of Other financing activities readings, the most recent being $303000.0 for Q1 2026.

Quarterly Other financing activities changed N/A to $303000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $303000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $99.6 million for FY2020, N/A changed from the prior year.
Other financing activities hit $303000.0 in Q1 2026 for Kodiak Sciences, down from $99.6 million in the prior quarter.
Across five years, Other financing activities topped out at $303000.0 in Q1 2026 and bottomed at $303000.0 in Q1 2026.